Статьи журнала - Сибирский онкологический журнал

Все статьи: 3757

Factors of cancer diagnosed family and medical system for delay in diagnosis and treatment of esophageal cancer

Factors of cancer diagnosed family and medical system for delay in diagnosis and treatment of esophageal cancer

Majeed Khan I., Hussain M., Latif A., Sarwar A.

Статья научная

Introduction. The esophagus cancer patients needs early diagnosis to achieve better prognosis. The delay barriers increase progression of diseases to higher stages. The aim of work was to identify and explore the barriers in diagnosis of esophagus cancer and chart the time duration in this process. Material and Methods. The study was conducted in Jinnah Hospital Lahore (JHL), a teaching care hospital of Allama Iqbal Medical College, during a period of one year from July 2019 to July 2020. There were 49.42 % female and 50.57 % male patients.

Бесплатно

Feasibility of simultaneous integrated boost for high-dose treatment of high-risk prostate cancer

Feasibility of simultaneous integrated boost for high-dose treatment of high-risk prostate cancer

Sukhikh E.S., Sukhikh L.G., Taletsky A.V., Startseva Zh.A., Verkhoturova V.V., Rozanov V.V., Selikhova E.A.

Статья научная

Background. Radiation therapy for high-risk prostate cancer presents a challenge for cancer radiotherapists. The improvement of treatment outcomes is associated with radiation dose escalation and prophylactic irradiation of lymph nodes, therefore, the development of the new treatment schemes is needed. Simultaneous integrated boost technique based on the volumetric modulated arc therapy is the most efficient treatment option. Material and Methods. The anatomical data of 10 patients with high-risk prostate cancer was used for dosimetry-based treatment planning. Both simultaneous integrated boost and sequential boost technique were considered. The treatment planning goal was to deliver the equivalent dose of 96 Gy at 2 Gy per fraction (EQD2=96 Gy) (α/β=1.5 Gy) to the prostate, EQD2=62.5 Gy to the seminal vesicles and EQD2=50 Gy to lymph nodes avoiding damaging the organs at risk, mainly the bladder and rectum. The irradiation was based on volumetric modulated arc therapy with two partially coplanar arcs and two rotations at each arc. The obtained dose distributions were compared with respect to dose-volume histograms and equivalent uniform doses (EUD). Results. In the case of sequential boost, the minimal dose delivered to the prostate was equal to2cc95.9 ± 2.1 Gy, EUD=104.9 ± 1.7 Gy. The dose delivered to 2 cm3 ( D ) bladder was 97.4 ± 2.0 Gy. Normal tissue2cccomplication probability (NTCP) was 1.64 %. The dose delivered to 2 cm3 ( D ) rectum was 103.4 ± 9.2 Gyand NTCP was 27.4 %. In the case of simultaneous integrated boost, the minimal dose delivered to the prostate was equal to 90 . 4 ± 2 . 3 Gy, EUD= 103 . 9 ± 1 . 3 Gy. The bladder dose was as high as D 2cc = 96 . 1 ± 5 . 2 Gy, NTCP= 0 . 176 ± 0 . 132 %, the rectum dose - D 2cc = 81 . 1 ± 6 . 0 Gy, NTCP= 2 . 34 ± 1 . 92 %. Conclusion. Volumetric modulated arc therapy along with simultaneous integrated boost have shown the feasibility of simultaneous irradiation of the prostate, seminal vesicles and lymph nodes up to the prescribed dose values without significant over irradiation of the organs at risk (OARs). Dose values in the tumor as high as EUD= 103 . 9 ± 1 . 3 Gy along with prophylactic irradiation of lymph nodes may result in higher tumor control probability value and should be considered for clinical trials.

Бесплатно

First dorsal metacarpal artery flap in soft tissue reconstruction of recurrent thumb squamous cell carcinoma

First dorsal metacarpal artery flap in soft tissue reconstruction of recurrent thumb squamous cell carcinoma

Pauline Yap, Arman Zaharil Mat Saad, Wan Azman Wan Sulaiman, Siti Fatimah Noor Mat Johar, Nurul Syazana Mohamad Shah

Статья научная

Background. Subungual squamous cell carcinoma (SCC) of thumb is a rare disease. However, it is the most common malignancy affecting the nail bed. Early recognition is crucial and important for prompt diagnosis and effective treatment. Often this tumour needs to be treated surgically with wide local resection, which results in a defect in the thumb. If not handled appropriately, such defects render restriction in functionality of the involved thumb as well as a poor aesthetic outcome. In the worst-case scenario, it may result in a poor function of involved hand. Thus, reconstruction of the involved thumb is necessary. The main aim of reconstruction is to regain the hands’ function and preserved the thumbs’ sensation. Secondarily, to have an aesthetically pleasing hand. Our hands carry out delegate job and important duty for daily function. Especially, the thumb working together with the other fingers to carry out the hand function as one unit. Loss of thumb function affects the whole performance of the hand. Case descriptions. We report a case of recurrent subungual squamous cell carcinoma of thumb, which had wide local resection and subsequently underwent soft tissue coverage with an islanded first dorsal metacarpal artery (FDMA) perforator flap. One month after surgery, the patient was able to regain a good functional outcome of the hand. In this report, we discussed the procedures that had been done. Conclusion. The patient regained full functional hand after reconstruction with preserved sensation over distal thumb. The aesthetic outcome is satisfactory. The FDMA perforator flap is a very pliable and robust flap for reconstruction of distal thumb defect.

Бесплатно

Four secondary malignancies, coronary artery disease, aortic atherosclerosis and severe constrictive pericarditis in a survivor of Hodgkin lymphoma treated with radiation therapy: a case report

Four secondary malignancies, coronary artery disease, aortic atherosclerosis and severe constrictive pericarditis in a survivor of Hodgkin lymphoma treated with radiation therapy: a case report

Jeri-yabar A., Garazatua-gonzalez J., Montoya-rivera W., Ortuzar-seminario V., Lozada Zingoni C., Massuco V.

Статья научная

Introduction. Radiation therapy (RT) has been widely used since the 1970s in the treatment of Hodgkin’s lymphoma. RT increases the risk of secondary malignancies and heart disease including coronary artery disease, noncoronary atherosclerotic valvular disease, valvular dysfunction, pericardial disease and radiation induced vasculopathy. Case Presentation. We describe a case of a patient with 4 secondary malignancies due to previous RT including parotid mucoepidermoid carcinoma, breast multicentric infiltrating ducta, thyroid papillary microcarcinoma with follicular pattern and lung adenocarcinoma that later presented with severe constrictive pericarditis, which led to an emergency pericardiectomy - all of these were complications of her previous radiotherapy. She received a prompt diagnosis and treatment. Discussion. Radiation-induced vascular disease (RIVD) occurs due to endothelial injury following RT; patients have up to 3-4 fold increase in risk of myocardial infarction due to CAD, therefore screening of CAD with a CT coronary angiography is recommended to begin 5 years after receiving RT in patients 45 and older and 10 years after RT in patients

Бесплатно

From editor-in-chief

From editor-in-chief

Ред. заметка

Бесплатно

Giant foam-like macrophages in advanced ovarian cancer

Giant foam-like macrophages in advanced ovarian cancer

Rakina M.A., Kazakova E.O., Sudarskikh T.S., Bezgodova N.V., Villert A.B., Kolomiets L.A., Larionova I.V.

Статья научная

Introduction. Ovarian cancer (OC) is the third most common gynecological cancer with the worst prognosis and highest mortality rate. The progression of OC can be accompanied by the detrimental functions of the components of the tumor microenvironment, including tumor-associated macrophages (TAMs). The purpose of the study to analyze distribution and morphological phenotype of TAMs in tumor tissue of patients with high-grade serous ovarian cancer (HGSOC). Material and Methods. Formalin fixed paraffin embedded tissue sections were obtained from ovarian cancer patients after tumor resection. The protein expression of general macrophage marker CD68 and M2-like markers CD206, CD163 and stabilin-1, belonging to scavenger receptors, was analysed by immunohistochemical staining in tumor tissue. Histological assessment of TAM distribution was performed by pathologist. Immunofluorescent analysis/confocal microscopy was applied to establish the co-expression of CD68 with the main macrophage scavenger receptors. Results. We were able to find giant CD68-positive macrophages with foamy cytoplasm in ovarian tumor tissue. The accumulation of these TAMs was specific only for patients with advanced stage (IIIC and IV stages). The presence of foam-like TAMs had a statistical tendency to be associated with ovarian cancer progression, including metastasis and recurrence. The distribution of stabilin-1-positive macrophages was matched to CD68 expression in almost all cases, as was shown by IHC. Confocal microscopy confirmed that stabilin-1 was expressed in at least 50 % of giant TAMs. IF analysis of tumor samples also demonstrated co-expression of other scavenger receptors, CD163 and CD36, in foam-like cells. Similar to IHC, in most samples the expression of CD206 in TAMs of foam-like morphology was limited. Conclusion. For the first time we demonstrated the accumulation of giant macrophages with fluffy foam cytoplasm in the tumor tissue of treated patients with advanced ovarian cancer. Such macrophages express diverse scavenger receptors (stabilin-1, CD163, CD36), thus indicating a high clearance activity of giant TAMs.

Бесплатно

HRD-негативная карцинома яичника высокой степени злокачественности у пациентки с наследственной мутацией BRCA2

HRD-негативная карцинома яичника высокой степени злокачественности у пациентки с наследственной мутацией BRCA2

Соколенко А.П., Полетаева С.В., Шестакова А.Д., Городнова Т.В., Берлев И.В., Имянитов Е.Н.

Статья научная

Актуальность. Дефицит гомологичной рекомбинации (HRD) - это важный предиктивный маркер эффективности препаратов платины и ингибиторов поли (АДФ-рибоза)-полимеразы (PARP). Наследственные или соматические мутации генов BRCA1 или BRCA2 являются наиболее частой причиной HRD в карциномах яичника . Однако в некоторых случаях у носителей патогенных наследственных мутаций BRCA1/2 в опухоли сохраняется нормальная копия соответствующего гена и фенотип HRD не формируется. Цель исследования - описание морфологического и молекулярного портрета карциномы яичника высокой степени злокачественности у пациентки с наследственной мутацией BRCA2, не демонстрирующей дефицита гомологичной репарации ДНК. Описание клинического случая. Представлено наблюдение пациентки, 48 лет, с синхронными первично-множественными злокачественными новообразованиями: high-grade карциномой яичника и колоректальной аденокарциномой. У пациентки выявлен известный патогенный вариант BRCA2 c.658_659delGT [rs80359604]. Учитывая неопределенный гистологический вариант низкодифференцированной карциномы, а именно, отсутствие экспрессии маркеров серозной или эндометриоидной дифференцировки, а также высокую экспрессию HER2, выполнено дополнительное молекулярное исследование метастатических очагов в лимфатические узлы. Обнаружено, что в данной опухоли профиль хромосомной нестабильности не соответствует HRD и наблюдается делеция мутантного аллеля BRCA2, что исключает BRCA-подобный фенотип.

Бесплатно

Hereditary diffuse gastric cancer: genetic aspects and prophylactic total gastrectomy

Hereditary diffuse gastric cancer: genetic aspects and prophylactic total gastrectomy

Lyubchenko Liudmila N., Filippova Margarita G., Anurova Olga A., Nazliev Pavel B., Stilidi Ivan S.

Статья научная

For patients with an identified germline E-cadherin-1 ( CDH1 ) mutation, prophylactic gastrectomy is the treatment of choice to eliminate the high risk of developing diffuse gastric cancer. The case report describes a rare case of hereditary diffuse gastric cancer (HDgC) associated with CDH1 gene mutation, which is reported in the Russian population for the first time. In 2013, a 28-year-old woman was referred to Clinical Oncogenetics Laboratory with a family history of gastric cancer. Molecular genetic analysis revealed CDH1 gene mutation. The lifetime risk of cancer in mutation positive members is more than 80. Histological examination of gastric biopsy specimens obtained during endoscopy revealed isolated signet ring cells in the lamina propria. Spleen-preserving D2-lymphodissection and total gastrectomy with Roux-en-Y reconstruction with a jejunal reservoir formation were performed at the Abdominal Oncology Surgery Department.

Бесплатно

IFN-индуцированные дендритные клетки у больных множественной миеломой

IFN-индуцированные дендритные клетки у больных множественной миеломой

Леплина О.Ю., Насонова Г.В., Тихонова М.А., Крючкова И.В., Лисуков И.А., Останин А.А., Черных Е.Р.

Статья научная

Проведено сравнительное исследование фенотипических и функциональных свойств дендритных клеток (ДК), генери- рованных in vitro в присутствии GM-CSF и IFN-α, у здоровых доноров (n=34) и больных множественной миеломой (n=12). Показано, что по своему составу (количеству зрелых/незрелых ДК и клеток промежуточной степени зрелости) популяция ДК больных в целом была сопоставима с ДК здоровых доноров. ДК больных множественной миеломой (ММ) не отличались от ДК доноров по уровню продукции IFN-γ и TNF-α. В то же время ДК больных характеризовались более низким содержанием активированных CD25+клеток в сочетании с повышенной продукцией IL-10, что, по-видимому, обусловливало ослабление их стимуляторной активности в СКЛ. Тем не менее ДК больных ММ сохраняли свою способность к запуску Th1-ответа, что проявлялось 5-кратным увеличением количества CD3+IFN-γ+ Т-клеток. Полученные данные аргументируют возмож- ность клинического применения ДК у больных ММ в качестве клеточных вакцин (особенно в сочетании с адъювантной цитокинотерапией) с целью повышения эффективности противоопухолевого иммунного ответа.

Бесплатно

II фаза оценки эффективности метрономного режима введения цитостатиков у больных диссеминированными солидными опухолями

II фаза оценки эффективности метрономного режима введения цитостатиков у больных диссеминированными солидными опухолями

Чубенко В.А., Проценко С.А., Михайличенко Т.Д., Семенова А.И., Телетаева Г.М., Новик А.В., Брежнев Н.В., Жабина А.С., Моисеенко Ф.В., Волков Н.М., Моисеенко В.М.

Статья

Бесплатно

Impact of obesity on the oncological and surgical outcomes of thigh soft tissue sarcoma

Impact of obesity on the oncological and surgical outcomes of thigh soft tissue sarcoma

Hamdy O., Atallah Kh., Ros M.H., Metwally I.H.

Статья научная

Background. malignant soft tissue tumors are a heterogeneous group with variable prognosis and with a tendency to recurrence and distant spread, mainly to the lungs. also, obesity is a known risk factor for many diseases and cancers and is currently a global problem. While the thigh is one of the main fat deposition areas, it is one of the commonest sites for the incidence of soft tissue sarcoma. We tried to illustrate the impact of obesity on the outcomes of thigh soft tissue sarcoma patients. material and methods. We retrospectively recruited data of extremity sarcomas treated at our hospital from January 2008 to January 2020. the epidemiological and clinical data of all the included patients was analyzed, then the surgical and oncological outcomes between obese and non-obese patients were compared (defining obesity as Bmi more than 30). We hypothesized that fat deposition in the thigh in obese patients may delay the diagnosis of soft tissue sarcoma, lead to the discovery of the masses at a larger size and stage, and hence may affect the disease-free survival and the overall survival. Results. obese patients had significantly larger size tumors (median: 14.7 vs 9.9 cm) and as such significantly higher t stage. another significant finding was that the mean diameter of liposarcoma tumours was 15.1 cm, while that of non-liposarcomas was 11.3 cm (p-value=0.023). also, although they did not have a higher prevalence of distant metastasis at initial diagnosis, their metastasis tends to be isolated in the lung. postoperative complications occurred more frequently in obese patients in comparison to non-obese patients (p-value=0.025). Neither overall nor disease-free survivals were different among both groups, although obese patients tend to have shorter dFs. conclusion. obesity added complexity to the diagnosis and treatment of extremity sarcoma, but seems not to affect survival.

Бесплатно

Impact of transcription factors, VEGF and proteases on kidney cancer progression

Impact of transcription factors, VEGF and proteases on kidney cancer progression

Spirina Liudmila V., Kondakova Irina V., Usynin Evgeny A., Slonimskaya Elena M., Yurmazov Zahar A.

Статья научная

Introduction. The efficacy of anticancer treatment depends on biological factors of tumor. the aim of the study was to determine the activity of proteasomes and calpains and to reveal their association with VEgF, HIF-1α and NF-κΒ expressions in normal, primary and metastatic renal cell carcinoma (RCC) tissues. methods. Ninety-three patients with renal cell carcinoma were included into the study. The expression levels of transcription factor and VEgF were measured using ELISA kits. The levels of proteasome subunits were measured by Western blotting. Proteasome and calpain activities were determined using specific fluorogenic substrates. results. We revealed inactivation of proteolysis in patients with kidney cancer. Disease advance was associated with a significant depression of cellular proteolysis and increase in transcription and growth factor levels in primary kidney cancer tissues. The proteolysis activation was found in metastatic tissues. Conclusions. Our results suggest that NF-κΒ, HIF-1α and VEgF transcription factors and intracellular proteolytic systems are involved in kidney cancer progression.

Бесплатно

Induction of epithelial-to-mesenchymal transition in MCF-7-SNAI1 cells leads to reorganization of adherens junctions and acquisition of migratory activity

Induction of epithelial-to-mesenchymal transition in MCF-7-SNAI1 cells leads to reorganization of adherens junctions and acquisition of migratory activity

Zhitnyak Irina Y., Litovka Nikita I., Rubtsova Svetlana N., Gloushankova Natalya A.

Статья научная

Using DIC and confocal microscopy, changes in morphology, migratory characteristics and adherence junctions (AJs) were analyzed in the mammary carcinoma cell line MCF-7-SNAI1 after activation of the EMT transcription factor SNAI1. Western blot analysis showed that after removal of tetracycline from the cell culture medium expression of SNAI1 reached its peak in 24 hours and then plateaued for 7 days. During the 7 days the cells continued to express E-cadherin; however, tangentialAJs typical for cells with stable cell-cell adhesion, changed into radial AJs. The radial AJs continued to accumulate E-cadherin during 24-72 hours after tetracycline removal. As a result of SNAI1 activation, the cells underwent epithelial-mesenchymal transition (EMT) and became migratory. On a two-dimensional substrate, cells exhibited both individual and collective migration. As the tetracycline washout period progressed, the fraction of the cells capable of migrating through migration chamber membranes increased; on the contrary, cells’ ability to invade an epithelial monolayer decreased. These results demonstrate that retaining a hybrid epithelial/mesenchymal phenotype and accumulation of E-cadherin in AJs during early stages of EMT do not impede disruption of stable cell-cell adhesion and cells’ acquisition of migratory activity.

Бесплатно

KRAS-мутированный немелкоклеточный рак легкого: новые стратегии терапии

KRAS-мутированный немелкоклеточный рак легкого: новые стратегии терапии

Лактионов К.К., Саранцева К.А., Нелюбина Л.А., Гамаюнов С.В., Колесникова Е.А., Гордиев М.Г.

Статья научная

Рак легкого остается одним из наиболее опасных и распространенных видов онкологических заболеваний, требующих постоянного совершенствования методов диагностики и лечения. легкого В попытке добиться большей эффективности для отдельных групп пациентов генетическая неоднородность рака заставляет искать новые терапевтические мишени. Цель исследования - обновление текущих знаний об аденокарциноме легкого с мутацией в гене KRAS, рассмотрение новых возможностей персонализированного лечения KRAS-мутированного НМРЛ и формирование образа российского пациента, которому потенциально показана таргетная терапия. Материал и методы. Проведен поиск доступных литературных источников, опубликованных в базе данных Pubmed, Cochrane Library, Elibrary, включались публикации, относящиеся к 2008-2023 гг.

Бесплатно

Laser induced autofluorescence of normal and metaplastic epithelium of esophagogastric transition at gastroesophageal reflux disease

Laser induced autofluorescence of normal and metaplastic epithelium of esophagogastric transition at gastroesophageal reflux disease

Dronova O.B., Tretyakov A.A., Mishchenko A.N., Bulgakova N.N.

Статья научная

In vivo autofluorescence of normal and metaplastic epithelium of esophagogastric transition in patients with reflux-esophagitis was studied by local fluorescence spectroscopy under 532 nm excitation. It was shown that application of in vivo local fluorescence spectroscopy during gastroesophagoscopy makes it possible to improve a quality of diagnostics of Barrett's esophagus. Key words: gastroesophageal reflux disease, Barrett's esophagus, fluorescent diagnosis, local fluorescent spectroscopy.

Бесплатно

Loss of heterozygosity in the BRCA1 and BRCA2 locus in breast cancer

Loss of heterozygosity in the BRCA1 and BRCA2 locus in breast cancer

Tsyganov Matvey M., Ibragimova Marina K., Pevzner Alina M., Litviakov Nikolay V.

Статья научная

One of the factors of variability of malignant neoplasms is the loss of heterozygosity (LOH). The biological meaning of LOH, in relation to carcinogenesis, is associated with the inactivation of heterozygous loci of pathogenetically significant genes. Thus, the aim of this work was to study BRCA1/2 LOH in breast tumors. Material and Methods. The study included 122 patients with stage IIAIIIC breast cancer. DNA was isolated from 122 biopsy samples of tumor tissue using the QIAamp DNA mini Kit (Qiagen, Germany). To assess the status of LOH, microarray analysis was performed on high-density DNA chips from Affymetrix CytoScanTM HD Array. To process the results of microchipping, we used the Chromosome Analysis Suite 3.3 program (Affymetrix, USA). Results. The loss of heterozygosity in the BRCA1 gene was found to be associated with response to NAC. It was shown that in 59 patients LOH in the BRCA1gene was associated with an objective response to treatment (p=0.005). The presence of LOH in the studied genes was associated with a favorable prognosis. The 5-year non-metastatic survival rates were 75 % and 100 % in patients with LOH in the BRCA1 and BRCA2 genes, respectively (log-rank test: p=0.003 and p=0.05, respectively). Conclusion. The phenomenon of LOH in the BRCA1/2 genes was shown to be associated with response to NACT. BRCA1/2. Further studies are needed to evaluate the frequency of BRCA1/2 LOH after NAC for choosing and changing treatment tactics.

Бесплатно

MIR-155 и MIR-223 как маркеры клинических особенностей течения хронического лимфолейкоза

MIR-155 и MIR-223 как маркеры клинических особенностей течения хронического лимфолейкоза

Перепечаева М.Л., Горева О.Б., Березина О.В., Поспелова Т.И., Гришанова А.Ю.

Статья научная

Введение. Хронический лимфолейкоз (ХЛЛ) - заболевание, которое характеризуется высокой межиндивидуальной гетерогенностью как клинического течения, так и молекулярных паттернов экспрессии генов и регуляторных РНК, способных оказывать влияние на патологический процесс. Вовлеченность регуляторных miR-155 и miR-223 в патогенез ХЛЛ в целом известна, но информации о возможных колебаниях экспрессии miR-155 и miR-223 в зависимости от динамики развития патологического процесса и характеристик врачебного вмешательства недостаточно. Цель исследования - изучение уровня экспрессии miR-155 и miR-223 у больных ХЛЛ с разными биологическими, клиническими особенностями и характеристиками проводимой терапии в субстратах периферической крови: плазме, лимфоцитах, внеклеточных везикулах, а также в костном мозге. Материал и методы. При выполнении работы использовались образцы периферической крови и костного мозга 38 пациентов с диагнозом ХЛЛ из Городского гематологического центра ГБУЗ Новосибирской области «Городская клиническая больница № 2» с 2016 по 2017 г. Оценка уровня экспрессии miR-155 и miR-223 проводилась методом ОТ-ПЦР в реальном времени по принципу TaqMan. Оценку значимости различий групп проводили с помощью непараметрического критерия Манна-Уитни либо непараметрического критерия Краскела-Уоллиса с последующим попарным сравнением с помощью критерия Манна-Уитни.

Бесплатно

Memory of G.F. Ginsburg

Memory of G.F. Ginsburg

Персоналии

Бесплатно

Memory of academician RAMS A.F. Tsyb

Memory of academician RAMS A.F. Tsyb

Персоналии

Бесплатно

Журнал